Skip to main content
Top
Published in: Endocrine 2/2013

01-04-2013 | Original Article

Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus

Authors: Wen-Jin Fu, Yao-Gao Fang, Ren-Tang Deng, Shu Wen, Mei-Lian Chen, Zhi-Hong Huang, Hui-Hua Tang, Shi-Long Xiong, Xian-Zhang Huang, Qian Wang

Published in: Endocrine | Issue 2/2013

Login to get access

Abstract

The aim of this study was to assess the relationship between urinary Smad1 and glomerular hyperfiltration (GHF) in type 2 diabetes mellitus (T2DM), and to explore the factors related to the urinary Smad1 in T2DM. The reference value of the estimated glomerular filtration rate (eGFR) was determined in 248 healthy individuals. 30 patients with GHF, 58 patients with norm-GFR T2DM, and 24 healthy patients who served as controls were recruited. Urinary Smad1, fasting plasma glucose (FPG), fasting serum C-Peptide (C-P), hemoglobin A1C (HbA1c), cystatin C, and other chemistry laboratory parameters of T2DM participants and controls were measured. Patients with GHF had higher levels of urinary Smad1 than the control group, and those with norm-GFR. For T2DM patients with body mass index, age, and gender adjustments, urinary Smad1 was positively correlated with FPG, HbA1C, and eGFR, but negatively correlated with fasting serum C-P. Multivariate linear regression analysis demonstrated that eGFR, HbA1C, and fasting serum C-P were independently associated with urinary Smad1. High levels of urinary Smad1 were found in GHF patients with T2DM, which may be another potential mechanism of GHF in relation to diabetic nephropathy.
Literature
1.
go back to reference M. Krolewski, P.W. Eggers, J.H. Warram, Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int. 50, 2041–2046 (1996)PubMedCrossRef M. Krolewski, P.W. Eggers, J.H. Warram, Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int. 50, 2041–2046 (1996)PubMedCrossRef
2.
go back to reference M. Bojestig, H.J. Arnqvist, G. Hermansson et al., Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N. Engl. J. Med. 330, 15–18 (1994)PubMedCrossRef M. Bojestig, H.J. Arnqvist, G. Hermansson et al., Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N. Engl. J. Med. 330, 15–18 (1994)PubMedCrossRef
3.
go back to reference B.M. Brenner, Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int. 23, 647–655 (1983)PubMedCrossRef B.M. Brenner, Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int. 23, 647–655 (1983)PubMedCrossRef
4.
go back to reference W.J. Fu, S.L. Xiong, Y.G. Fang et al., Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine 41, 82–88 (2012)PubMedCrossRef W.J. Fu, S.L. Xiong, Y.G. Fang et al., Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine 41, 82–88 (2012)PubMedCrossRef
5.
go back to reference M. von Eynatten, M. Baumann, U. Heemann et al., Urinary L-FABP and anaemia: distinct roles of urinary markers in type diabetes. Eur. J. Clin. Investig. 40, 95–102 (2010)CrossRef M. von Eynatten, M. Baumann, U. Heemann et al., Urinary L-FABP and anaemia: distinct roles of urinary markers in type diabetes. Eur. J. Clin. Investig. 40, 95–102 (2010)CrossRef
6.
go back to reference T. Matsubara, H. Abe, H. Arai et al., Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy. Lab. Investig. 86(4), 357–368 (2006)PubMedCrossRef T. Matsubara, H. Abe, H. Arai et al., Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy. Lab. Investig. 86(4), 357–368 (2006)PubMedCrossRef
7.
go back to reference P.A. Hoodless, T. Haerry, S. Abdollah et al., MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85, 489–500 (1996)PubMedCrossRef P.A. Hoodless, T. Haerry, S. Abdollah et al., MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85, 489–500 (1996)PubMedCrossRef
8.
go back to reference M. Wang, H. Jin, D. Tang et al., Smad1 plays an essential role in bone development and postnatal bone formation. Osteoarthritis Cartil. 19(6), 751–762 (2011)CrossRef M. Wang, H. Jin, D. Tang et al., Smad1 plays an essential role in bone development and postnatal bone formation. Osteoarthritis Cartil. 19(6), 751–762 (2011)CrossRef
9.
go back to reference K.D. Tremblay, N.R. Dunn, E. Robertson, Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 28, 3609–3621 (2001) K.D. Tremblay, N.R. Dunn, E. Robertson, Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 28, 3609–3621 (2001)
10.
go back to reference Rosolowsky ET, Niewczas MA, Ficociello LH, et al., Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy. Diabetes. Res. Clin. Pract. 13(S1), S46–53 (2008) Rosolowsky ET, Niewczas MA, Ficociello LH, et al., Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy. Diabetes. Res. Clin. Pract. 13(S1), S46–53 (2008)
11.
go back to reference B.M. Brenner, T.W. Meyer, T.H. Hostetter, Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N. Engl. J. Med. 307, 652–659 (1982)PubMedCrossRef B.M. Brenner, T.W. Meyer, T.H. Hostetter, Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N. Engl. J. Med. 307, 652–659 (1982)PubMedCrossRef
12.
go back to reference M.P. O’Donnell, B.L. Kasiske, W.F. Keane, Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J. 2(8), 2339–2344 (1988)PubMed M.P. O’Donnell, B.L. Kasiske, W.F. Keane, Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J. 2(8), 2339–2344 (1988)PubMed
13.
go back to reference G. Gruden, S. Thomas, D. Burt et al., Mechanical stretch induces vascular permeability factor in human mesangial cells: Mechanisms of signal transduction Proc. Natl. Acad. Sci. USA 94, 12112–12116 (1997)CrossRef G. Gruden, S. Thomas, D. Burt et al., Mechanical stretch induces vascular permeability factor in human mesangial cells: Mechanisms of signal transduction Proc. Natl. Acad. Sci. USA 94, 12112–12116 (1997)CrossRef
14.
go back to reference W.J. Fu, B.L. Li, S.B. Wang et al., Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration. Diabetes Res. Clin. Pract. 95(1), 105–109 (2012)PubMedCrossRef W.J. Fu, B.L. Li, S.B. Wang et al., Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration. Diabetes Res. Clin. Pract. 95(1), 105–109 (2012)PubMedCrossRef
15.
go back to reference R.J. Macisaac, C. Tsalamandris, M.C. Thomas et al., Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia 49, 1686–1689 (2006)PubMedCrossRef R.J. Macisaac, C. Tsalamandris, M.C. Thomas et al., Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia 49, 1686–1689 (2006)PubMedCrossRef
16.
go back to reference L.H. Ficociello, B.A. Perkins, B. Roshan et al., Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care 32, 889–893 (2009)PubMedCrossRef L.H. Ficociello, B.A. Perkins, B. Roshan et al., Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care 32, 889–893 (2009)PubMedCrossRef
17.
go back to reference R. Bruce, M. Rutland, T. Cundy, Glomerular hyperfiltration in young Polynesians with type 2 diabetes. Diab. Res. Clin. Pract. 25, 155–160 (1994)CrossRef R. Bruce, M. Rutland, T. Cundy, Glomerular hyperfiltration in young Polynesians with type 2 diabetes. Diab. Res. Clin. Pract. 25, 155–160 (1994)CrossRef
18.
go back to reference P. Vedel, J. Obel, F.S. Nielsen et al., Glomerular hyperfiltration in microalbuminuric NIDD patients. Diabetologia 39, 1584–1589 (1996)PubMedCrossRef P. Vedel, J. Obel, F.S. Nielsen et al., Glomerular hyperfiltration in microalbuminuric NIDD patients. Diabetologia 39, 1584–1589 (1996)PubMedCrossRef
19.
go back to reference C.K. Keller, K.H. Bergis, D. Fliser, E. Ritz, Renal findings in patients with short-term type 2 diabetes. J. Am. Soc. Nephrol. 7, 2627–2635 (1996)PubMed C.K. Keller, K.H. Bergis, D. Fliser, E. Ritz, Renal findings in patients with short-term type 2 diabetes. J. Am. Soc. Nephrol. 7, 2627–2635 (1996)PubMed
20.
go back to reference S.P. Silviero, R. Friedman, M.J. Azevedo et al., Five year prospective study of the glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients. Diabetes Care 19, 171–174 (1996)CrossRef S.P. Silviero, R. Friedman, M.J. Azevedo et al., Five year prospective study of the glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients. Diabetes Care 19, 171–174 (1996)CrossRef
21.
go back to reference G.D. Tan, A.V. Lewis, T.J. James et al., Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care 25, 2004–2009 (2002)PubMedCrossRef G.D. Tan, A.V. Lewis, T.J. James et al., Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care 25, 2004–2009 (2002)PubMedCrossRef
22.
go back to reference Y. Jin, T. Moriya, K. Tanaka et al., Glomerular hyperfiltration in non-proteinuric and non-hypertensive Japanese type 2 diabetic patients. Diabetes Res. Clin. Pract. 71, 264–271 (2006)PubMedCrossRef Y. Jin, T. Moriya, K. Tanaka et al., Glomerular hyperfiltration in non-proteinuric and non-hypertensive Japanese type 2 diabetic patients. Diabetes Res. Clin. Pract. 71, 264–271 (2006)PubMedCrossRef
23.
go back to reference A. Mima, H. Arai, T. Matsubara et al., Urinary Smad1 is a novel marker to predict later on set of mesangial matrix expansion in diabetic nephropathy. Diabetes 57(6), 1712–1722 (2008)PubMedCrossRef A. Mima, H. Arai, T. Matsubara et al., Urinary Smad1 is a novel marker to predict later on set of mesangial matrix expansion in diabetic nephropathy. Diabetes 57(6), 1712–1722 (2008)PubMedCrossRef
24.
go back to reference G. Gruden, S. Zonca, A. Hayward et al., Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes 49(4), 655–661 (2000)PubMedCrossRef G. Gruden, S. Zonca, A. Hayward et al., Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes 49(4), 655–661 (2000)PubMedCrossRef
25.
go back to reference S.W. Hong, M. Isono, S. Chen et al., Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am. J. Pathol. 158(5), 1653–1663 (2001)PubMedCrossRef S.W. Hong, M. Isono, S. Chen et al., Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am. J. Pathol. 158(5), 1653–1663 (2001)PubMedCrossRef
26.
go back to reference H. Jia, L. Yu, B. Gao, Q. Ji, Association between the T869C polymorphism of transforming growth factor-beta 1 and diabetic nephropathy: a meta-analysis. Endocrine 40(3), 372–378 (2011)PubMedCrossRef H. Jia, L. Yu, B. Gao, Q. Ji, Association between the T869C polymorphism of transforming growth factor-beta 1 and diabetic nephropathy: a meta-analysis. Endocrine 40(3), 372–378 (2011)PubMedCrossRef
27.
go back to reference H. Abe, T. Matsubara, H. Arai et al., Role of Smad1 in diabetic nephropathy: molecular mechanisms and implications as a diagnostic marker. Histol. Histopathol. 26(4), 531–541 (2011)PubMed H. Abe, T. Matsubara, H. Arai et al., Role of Smad1 in diabetic nephropathy: molecular mechanisms and implications as a diagnostic marker. Histol. Histopathol. 26(4), 531–541 (2011)PubMed
28.
go back to reference C.E. Hills, N. Al-Rasheed, N. Al-Rasheed et al., C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 296(3), F614–F621 (2009)PubMedCrossRef C.E. Hills, N. Al-Rasheed, N. Al-Rasheed et al., C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 296(3), F614–F621 (2009)PubMedCrossRef
29.
go back to reference C.E. Hills, N.J. Brunskill, P.E. Squires, C-peptide as a therapeutic tool in diabetic nephropathy. Am. J. Nephrol. 31(5), 389–397 (2010)PubMedCrossRef C.E. Hills, N.J. Brunskill, P.E. Squires, C-peptide as a therapeutic tool in diabetic nephropathy. Am. J. Nephrol. 31(5), 389–397 (2010)PubMedCrossRef
Metadata
Title
Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus
Authors
Wen-Jin Fu
Yao-Gao Fang
Ren-Tang Deng
Shu Wen
Mei-Lian Chen
Zhi-Hong Huang
Hui-Hua Tang
Shi-Long Xiong
Xian-Zhang Huang
Qian Wang
Publication date
01-04-2013
Publisher
Springer US
Published in
Endocrine / Issue 2/2013
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9741-9

Other articles of this Issue 2/2013

Endocrine 2/2013 Go to the issue